Aggrastat tirofiban: Phase II started

Medicure began the open-label, U.S. Phase II SAVI-PCI trial to compare 25 µg/kg IV bolus of Aggrastat over 3 minutes followed by a shortened 0.15 µg/kg/min infusion over 1-2 hours vs. Integrilin eptifibatide infused over 12-18 hours in about 600 patients undergoing PCI. Medicure and Sarah Cannon Research Institute (SCRI) are sponsoring the study. ...